Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12583898 | Therapeutic interferon alpha 1 proteins | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12583903 | Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof | 🖼🧊📄§ | 2026-03-24 | 2042-06-03 | 0 | 31 |
| 12583910 | T cell antigen receptor, multimeric complex thereof, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-04-23 | 0 | 31 |
| 12583905 | Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells | 🖼🧊📄§ | 2026-03-24 | 2044-11-20 | 0 | 31 |
| 12583908 | Albumin protein variants, production thereof and uses of same | 🖼🧊📄§ | 2026-03-24 | 2045-01-16 | 0 | 31 |
| 12583916 | Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A) | 🖼🧊📄§ | 2026-03-24 | 2043-07-24 | 0 | 31 |
| 12583914 | Methods of treating allergy using anti-bet v 1 antibodies | 🖼🧊📄§ | 2026-03-24 | 2043-12-19 | 0 | 31 |
| 12583920 | Compositions and methods for treatment and prevention of Alzheimer's disease | 🖼🧊📄§ | 2026-03-24 | 2042-04-03 | 0 | 31 |
| 12583922 | Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2042-03-22 | 0 | 31 |
| 12583927 | Anti-variable MUC1* antibodies and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-12 | 0 | 31 |
| 12583928 | Antibodies against IGFR-like receptor and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2042-02-24 | 0 | 31 |
| 12583934 | Anti-CD26 antibodies and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2042-09-16 | 0 | 31 |
| 12583931 | Antibody and chimeric antigen receptor (CAR) binding to CD70, and application thereof | 🖼🧊📄§ | 2026-03-24 | 2041-10-12 | 0 | 31 |
| 12583932 | CD38 and ICAM1 antibodies and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2039-11-15 | 0 | 31 |
| 12583941 | Fibroblast activation protein binding agents and use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-03-27 | 0 | 31 |
| 12583938 | Protein biomarker and uses thereof | 🖼🧊📄§ | 2026-03-24 | 2043-11-08 | 0 | 31 |
| 12583945 | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof | 🖼🧊📄§ | 2026-03-24 | 2043-11-17 | 0 | 31 |
| 12584101 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | 🖼🧊📄§ | 2026-03-24 | 2043-09-22 | 0 | 31 |
| 12583892 | Conus-based toxin peptides, nucleic acids encoding same and uses thereof in modulating NMDA receptors | 🖼🧊📄§ | 2026-03-24 | 2042-06-28 | 0 | 31 |
| 12583890 | Methods for control of an infective disease with a vaccine | 🖼🧊📄§ | 2026-03-24 | 2042-09-20 | 0 | 31 |
| 12583888 | Bi-specific extracellular matrix binding peptides and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2040-02-03 | 0 | 31 |
| 12583815 | Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof | 🖼🧊📄§ | 2026-03-24 | 2041-07-02 | 0 | 31 |
| 12583821 | Salt of omecamtiv mecarbil and process for preparing salt | 🖼🧊📄§ | 2026-03-24 | 2044-01-24 | 0 | 31 |
| 12583848 | Isoxazole-3-carboxamide derivatives and their use for treatment of diseases caused by virus infection | 🖼🧊📄§ | 2026-03-24 | 2040-09-25 | 0 | 31 |
| 12583850 | Small molecule antiviral drug treatment for human papillomavirus infections | 🖼🧊📄§ | 2026-03-24 | 2045-08-07 | 0 | 31 |
| 12583857 | Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines | 🖼🧊📄§ | 2026-03-24 | 2043-12-21 | 0 | 31 |
| 12583865 | Biologically active taxane analogs and methods of treatment by oral administration | 🖼🧊📄§ | 2026-03-24 | 2043-09-27 | 0 | 31 |
| 12583867 | Pyridone derivative crystal form and preparation method and application therefor | 🖼🧊📄§ | 2026-03-24 | 2039-11-05 | 0 | 31 |
| 12582782 | Dry salt therapy device with converging-diverging nozzle | 🖼🧊📄§ | 2026-03-24 | 2042-08-12 | 0 | 31 |
| 12582809 | Treatment of a disease of the gastrointestinal tract with a PDE4 inhibitor | 🖼🧊📄§ | 2026-03-24 | 2039-01-24 | 0 | 31 |
| 12582729 | Kit technology for the production and long-term storage of Zr-89-PET radiopharmaceuticals | 🖼🧊📄§ | 2026-03-24 | 2039-01-25 | 0 | 31 |
| 12582727 | Chemiluminescent and fluorescent nanoparticle for optical imaging of cancer | 🖼🧊📄§ | 2026-03-24 | 2039-10-15 | 0 | 31 |
| 12582726 | Synthetic cancer-specific promoters | 🖼🧊📄§ | 2026-03-24 | 2045-05-23 | 0 | 31 |
| 12582721 | Molybdenum-based feed supplement for bees | 🖼🧊📄§ | 2026-03-24 | 2041-07-19 | 0 | 31 |
| 12582728 | Theranostic agents for PSMA positive cancers | 🖼🧊📄§ | 2026-03-24 | 2040-08-28 | 0 | 31 |
| 12582719 | Chimeric compounds and methods of managing neurological disorders or conditions | 🖼🧊📄§ | 2026-03-24 | 2040-02-25 | 0 | 31 |
| 12582715 | Cancer radiation therapy with biocompatible quantum dots for simultaneous dose enhancement and counter-metastasis | 🖼🧊📄§ | 2026-03-24 | 2042-10-21 | 0 | 31 |
| 12582712 | Method of making anti-pro/latent myostatin antibodies | 🖼🧊📄§ | 2026-03-24 | 2042-07-21 | 0 | 31 |
| 12582710 | Single-chain coronavirus viral membrane protein complexes | 🖼🧊📄§ | 2026-03-24 | 2041-08-27 | 0 | 31 |
| 12582711 | RNA-based adjuvant to enhance the immune response to vaccines and therapeutics | 🖼🧊📄§ | 2026-03-24 | 2042-08-18 | 0 | 31 |
| 12582713 | Methods of treating tumors | 🖼🧊📄§ | 2026-03-24 | 2044-01-25 | 0 | 31 |
| 12582709 | Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways | 🖼🧊📄§ | 2026-03-24 | 2041-07-01 | 0 | 31 |
| 12582707 | In-vitro transcript MRNA and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-03-24 | 2041-03-17 | 0 | 31 |
| 12582708 | Recombinant influenza viruses comprising truncated NS1 fusion proteins | 🖼🧊📄§ | 2026-03-24 | 2040-02-10 | 0 | 31 |
| 12582700 | Activin receptor type IIA variants and methods of use thereof | 🖼🧊📄§ | 2026-03-24 | 2045-06-05 | 0 | 31 |
| 12582703 | Blood substitutes comprising hemoglobin and methods of making | 🖼🧊📄§ | 2026-03-24 | 2042-11-08 | 0 | 31 |
| 12582704 | Food composition for improving behavioral and motor function containing aldehyde dehydrogenase for reducing aldehydes produced by oxidation of alcohol | 🖼🧊📄§ | 2026-03-24 | 2044-08-09 | 0 | 31 |
| 12582701 | Interleukin-18 variants and methods of use | 🖼🧊📄§ | 2026-03-24 | 2043-11-03 | 0 | 31 |
| 12582699 | Compositions and methods for enhanced lymphocyte-mediated immunotherapy | 🖼🧊📄§ | 2026-03-24 | 2040-02-12 | 0 | 31 |
| 12582698 | Cellular reprogramming to reverse aging and promote organ and tissue regeneration | 🖼🧊📄§ | 2026-03-24 | 2044-02-21 | 0 | 31 |